×
Omnicell Price to Free Cash Flow Ratio 2010-2024 | OMCL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Omnicell price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
View More
Omnicell Price to Free Cash Flow Ratio 2010-2024 | OMCL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Omnicell price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Tempus AI (TEM)
$11.4B
Inspire Medical Systems (INSP)
$5.9B
Hims & Hers Health (HIMS)
$5B
Axonics (AXNX)
$3.6B
IRhythm Technologies (IRTC)
$2.7B
Enovis (ENOV)
$2.6B
Privia Health (PRVA)
$2.5B
Azenta (AZTA)
$2.2B
10x Genomics (TXG)
$1.9B
Clover Health Investments (CLOV)
$1.7B
Schrodinger (SDGR)
$1.4B
Phreesia (PHR)
$1.2B
Standard BioTools (LAB)
$800M
Fulgent Genetics (FLGT)
$589M
Butterfly Network (BFLY)
$558M
Talkspace (TALK)
$555M
Definitive Healthcare (DH)
$500M
Health Catalyst (HCAT)
$498M
Pulmonx (LUNG)
$294M
SOPHiA GENETICS SA (SOPH)
$230M
TruBridge (TBRG)
$203M
American Well (AMWL)
$135M
P3 Health Partners (PIII)
$134M
EUDA Health Holdings (EUDA)
$108M
HeartBeam (BEAT)
$68M
Future Health ESG (FHLT)
$65M
111 (YI)
$59M
Zepp Health (ZEPP)
$49M
SHL Telemedicine (SHLT)
$45M
CareCloud (CCLD)
$44M